Based on the Shionogi & Co. Ltd. stock forecast from 0 analysts, the average analyst target price for Shionogi & Co. Ltd. is not available over the next 12 months. Shionogi & Co. Ltd.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Shionogi & Co. Ltd. is Slightly Bullish , which is based on 6 positive signals and 3 negative signals. At the last closing, Shionogi & Co. Ltd.’s stock price was JPY 2,194.50. Shionogi & Co. Ltd.’s stock price has changed by +0.92% over the past week, +6.55% over the past month and -5.34% over the last year.
No recent analyst target price found for Shionogi & Co. Ltd.
No recent average analyst rating found for Shionogi & Co. Ltd.
Company Overview Shionogi & Co. Ltd.
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug. It also develops S-872600 an influenza nasal vaccine; S-875670 anCOVID-19 nasal vaccine; S-540956 a nucleic acid adjuvant; S-554110 a nontuberculous mycobacterial infection; S-337395 for RSV infections; S-892216 for COVID-19 therapeutics; Olorofim for invasive aspergillosis; cefiderocol for aerobic gram-negative bacterial infections and infectious diseases; S-268019 a COVID-19 prophylactic vaccine; S-268019 a prophylactic vaccine for COVID-19; ensitrelvir for COVID-19 treatment and prevention; baloxavir for influenza virus infection; S-365598 for HIV infection; and S-555739 for suppressing aggravation of COVID-19. In addition, the company develops S-540956 for nucleic acid adjuvant; S-109802 for post-stroke spasticity; S-151128 for chronic pain; S-588210 and S-531011 for solid tumor; S-309309 for obesity; BPN14770 for Alzheimer's disease and fragile X syndrome; S-588410 for bladder cancer; S-488210 for head and neck squamous cell carcinoma; S-005151 for Acute ischemic stroke and epidermolysis bullosa; Rizmoic for opioid-induced constipation; ADR-001 for decompensated liver cirrhosis; S-222611 for malignant tumor; S-812217 for depression; GRT7039 for pain associated with osteoarthritis of the knee; SDT-001 for inattentive ADHD; S-588410 for esophageal cancer; SR-0379 for cutaneous ulcer; and S-723595 for type 2 diabetes. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan. Read Less
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-...Read More
Frequently Asked Questions About Shionogi & Co. Ltd. (4507:TSE) Stock
Stock Target Advisor's fundamental analysis for Shionogi & Co. Ltd.'s stock is Slightly Bullish .
4507:TSE stock's dividend yield is 2.58%.
Our analysis grades 4507:TSE stock's dividend yield at F. This means that 4507:TSE stock's dividend yield is above 35% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the TSE exchange.
Based on this 4507:TSE may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 4507:TSE's stock to indicate what its average analyst target is.
4507:TSE stock's Price/Earning ratio is 12.05.
Our analysis grades 4507:TSE stock's Price / Earning ratio at F. This means that 4507:TSE stock's Price/Earning ratio is above 42.00000000000001% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the TSE exchange.
Based on this 4507:TSE may be fairly valued for its sector
The last closing price of 4507:TSE's stock was JPY 2,194.50.
The most recent market capitalization for 4507:TSE is JPY 1,889.81B.
Unfortunately we do not have enough analyst data on 4507:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Shionogi & Co. Ltd.'s stock.
As per our most recent records Shionogi & Co. Ltd. has 4,959 Employees.
Shionogi & Co. Ltd.'s registered address is 1-8, Doshomachi 3-chome, Osaka, Japan, 541-0045.
You can get more information about it from Shionogi & Co. Ltd.'s website at https://www.shionogi.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Frequently Asked Questions About Shionogi & Co. Ltd. (4507:TSE) Stock
Stock Target Advisor's fundamental analysis for Shionogi & Co. Ltd.'s stock is Slightly Bullish .
4507:TSE stock's dividend yield is 2.58%.
Our analysis grades 4507:TSE stock's dividend yield at F. This means that 4507:TSE stock's dividend yield is above 35% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the TSE exchange.
Based on this 4507:TSE may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 4507:TSE's stock to indicate what its average analyst target is.
4507:TSE stock's Price/Earning ratio is 12.05.
Our analysis grades 4507:TSE stock's Price / Earning ratio at F. This means that 4507:TSE stock's Price/Earning ratio is above 42.00000000000001% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the TSE exchange.
Based on this 4507:TSE may be fairly valued for its sector
The last closing price of 4507:TSE's stock was JPY 2,194.50.
The most recent market capitalization for 4507:TSE is JPY 1,889.81B.
Unfortunately we do not have enough analyst data on 4507:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Shionogi & Co. Ltd.'s stock.
As per our most recent records Shionogi & Co. Ltd. has 4,959 Employees.
Shionogi & Co. Ltd.'s registered address is 1-8, Doshomachi 3-chome, Osaka, Japan, 541-0045.
You can get more information about it from Shionogi & Co. Ltd.'s website at https://www.shionogi.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4507:TSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
